412 related articles for article (PubMed ID: 25775370)
21. Acute pain associated with oxaliplatin infusion: case report and literature review.
Clay TD; Ashley DA
J Oncol Pharm Pract; 2012 Dec; 18(4):421-4. PubMed ID: 22080592
[TBL] [Abstract][Full Text] [Related]
22. Prospective pilot study of neoadjuvant chemotherapy with 5-fluorouracil, folinic acid and oxaliplatin in resectable liver metastases of colorectal cancer. Analysis of 42 neoadjuvant chemotherapies.
Lorenz M; Staib-Sebler E; Gog C; Proschek D; Jauch KW; Ridwelski K; Hohenberger W; Gassel HJ; Lehmann U; Vestweber KH; Padberg W; Zamzow K; Müller HH
Zentralbl Chir; 2003 Feb; 128(2):87-94. PubMed ID: 12632273
[TBL] [Abstract][Full Text] [Related]
23. 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction.
Fakih MG
Oncology; 2004; 67(3-4):222-4. PubMed ID: 15557782
[TBL] [Abstract][Full Text] [Related]
24. Multiorgan failure in a patient treated with the 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan regimen.
Schwartzman AD; Sethi R; Smith R
Clin Colorectal Cancer; 2013 Jun; 12(2):136-9. PubMed ID: 23098664
[No Abstract] [Full Text] [Related]
25. Hepatic arterial chemotherapy with oxaliplatin, folinic acid and 5-fluorouracil in pre-treated patients with liver metastases from colorectal cancer.
Del Freo A; Fiorentini G; Sanguinetti F; Muttini MP; Pennucci C; Mambrini A; Pacetti P; Della Seta R; Lombardi M; Torri T; Cantore M
In Vivo; 2006; 20(6A):743-6. PubMed ID: 17203759
[TBL] [Abstract][Full Text] [Related]
26. Conversion chemotherapy using cetuximab plus FOLFIRI followed by bevacizumab plus mFOLFOX6 in patients with unresectable liver metastases from colorectal cancer.
Uehara K; Ishiguro S; Hiramatsu K; Nishio H; Takeuchi E; Takahari D; Yoshioka Y; Takahashi Y; Ebata T; Yoshimura K; Muro K; Nagino M
Jpn J Clin Oncol; 2011 Oct; 41(10):1229-32. PubMed ID: 21840871
[TBL] [Abstract][Full Text] [Related]
27. [Adjuvant chemotherapy with FOLFOX4 regimen after curative resection of liver metastases from colorectal cancer].
Ohnishi T; Kanoh T; Tono T; Danno K; Watanabe A; Nakamura H; Tsukao Y; Inatome J; Kim T; Kagara N; Taniguchi H; Kimura Y; Nakano Y; Monden T; Imaoka S
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2554-6. PubMed ID: 21224637
[TBL] [Abstract][Full Text] [Related]
28. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ
Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231
[TBL] [Abstract][Full Text] [Related]
29. Cryptogenic organizing pneumonia during adjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX) for colon cancer.
Shogbon AO; Hap J; Dretler R; Dalvi AG
J Pharm Pract; 2013 Feb; 26(1):62-6. PubMed ID: 22842502
[TBL] [Abstract][Full Text] [Related]
30. [A case of intussusception due to sigmoid colon cancer during mFOLFOX6 therapy].
Kida K; Kawasaki A; Mimatsu K; Fukino N; Kuboi Y; Kano H; Oida T
Gan To Kagaku Ryoho; 2012 Oct; 39(10):1571-3. PubMed ID: 23064075
[TBL] [Abstract][Full Text] [Related]
31. [A case of ascending colon cancer successfully treated for synchronous liver metastases with mFOLFOX6 after a resection of the primary tumor].
Tomochika S; Hazama S; Nakatsu H; Yoshida S; Tokuhisa Y; Yoshino S; Oka M
Gan To Kagaku Ryoho; 2009 Nov; 36(12):2184-6. PubMed ID: 20037364
[TBL] [Abstract][Full Text] [Related]
32. Oxaliplatin-induced immune mediated thrombocytopenia.
Beg MS; Komrokji RS; Ahmed K; Safa MM
Cancer Chemother Pharmacol; 2008 Oct; 62(5):925-7. PubMed ID: 18204841
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.
De Vita F; Orditura M; Matano E; Bianco R; Carlomagno C; Infusino S; Damiano V; Simeone E; Diadema MR; Lieto E; Castellano P; Pepe S; De Placido S; Galizia G; Di Martino N; Ciardiello F; Catalano G; Bianco AR
Br J Cancer; 2005 May; 92(9):1644-9. PubMed ID: 15856038
[TBL] [Abstract][Full Text] [Related]
34. Is oxaliplatin combined with weekly bolus 5-fluorouracil and leucovorin an option for stage II and III colon cancer?
Twelves C
Nat Clin Pract Oncol; 2008 Feb; 5(2):72-3. PubMed ID: 18030299
[No Abstract] [Full Text] [Related]
35. Acute Disseminated Intravascular Coagulation after Oxaliplatin Infusion.
Waddle M; Irvin M; Gupta E; Gibbs M; Kakar TS; Gannon NA; Arthurs JR; Fischer DL; Ailawadhi S
Chemotherapy; 2017; 62(5):295-300. PubMed ID: 28505615
[TBL] [Abstract][Full Text] [Related]
36. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases.
Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM
Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717
[TBL] [Abstract][Full Text] [Related]
37. [A case of encephalopathy that was suspected to be caused by chemotherapy for colon cancer].
Ganno H; Fujiya K; Nakamura M; Takasaki J; Watayoh Y; Amagasa H; Kurokawa T; Ami K; Fukuda A; Nagahama T; Andoh M; Arai K
Gan To Kagaku Ryoho; 2011 Nov; 38(12):2322-4. PubMed ID: 22202369
[TBL] [Abstract][Full Text] [Related]
38. Hepatic arterial infusion with oxaliplatin, folinic acid, and 5-fluorouracil in patients with hepatic metastases from colorectal cancer: role of carcino-embryonic antigen in assessment of response.
Kern W; Beckert B; Lang N; Waggershauser T; Braess J; Schalhorn A; Hiddemann W
Anticancer Res; 2000; 20(6D):4973-5. PubMed ID: 11326650
[TBL] [Abstract][Full Text] [Related]
39. Clinical and radiological response with FOLFOXIRI and bevacizumab as third-line therapy after mFOLFOX6 and FOLFIRI failure.
de Melo JV; Vieira de Melo MS; Abad MH
Anticancer Drugs; 2011 Jun; 22 Suppl 2():S19-20. PubMed ID: 21768793
[TBL] [Abstract][Full Text] [Related]
40. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
Shitara K; Munakata M; Muto O; Kasai M; Okada R; Mitobe S; Sakata Y
Gan To Kagaku Ryoho; 2007 Jul; 34(7):1079-84. PubMed ID: 17637544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
